SEC Filing Summary

This filing reports a grant of 15,000 stock options to Dan Zabrowski, a director at ACTUATE THERAPEUTICS, INC. The options have an exercise price of $2.42 and an expiration date of May 21, 2036. They will vest in full on the anniversary of the grant date, May 21, 2026. Mr. Zabrowski acquired these options directly. The filing also notes that the number of shares acquired is 15,000, with a post-transaction ownership of 15,000 shares. The underlying security is Common Stock.